Compare BHVN & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHVN | ECPG |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2017 | 1999 |
| Metric | BHVN | ECPG |
|---|---|---|
| Price | $10.76 | $56.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | $30.36 | ★ $64.67 |
| AVG Volume (30 Days) | ★ 2.9M | 152.0K |
| Earning Date | 03-02-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,560,869,000.00 |
| Revenue This Year | N/A | $33.17 |
| Revenue Next Year | N/A | $2.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.52 |
| 52 Week Low | $7.48 | $26.45 |
| 52 Week High | $44.28 | $57.81 |
| Indicator | BHVN | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 59.95 |
| Support Level | $10.61 | $54.99 |
| Resistance Level | $12.90 | $56.96 |
| Average True Range (ATR) | 0.80 | 1.47 |
| MACD | -0.23 | 0.04 |
| Stochastic Oscillator | 17.66 | 85.75 |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.